Extravasation of antineoplastic drugs: assessment of the nursing team knowledge
avaliação do conhecimento da equipe de enfermagem
DOI:
https://doi.org/10.5935/2316-9389.2011.v15.50351Keywords:
nursing, antineoplastic, knowledge, extravasation of diagnostic and therapeutic materialsAbstract
Local dermatologic toxicity due to extravasation of antineoplastic drugs is one of the main adverse effects of antineoplastic therapy and it is considered an oncologic emergency. Its prevention is vital since it is a source of stress to the nursing team and it may cause irreparable harm to the patient. This study aimed to evaluate the knowledge of the nursing staff at an Adult Outpatient Chemotherapy Unit about antineoplastic drugs extravasation. It is an exploratory, descriptive and quantitative research carried out in a philantropic referral hospital for oncology in Curitiba (PR). The sample consisted of nine nursing staff employees (33% nurses and 67% practical nurses). The most cited extravasation signs and symptoms were "o edema" (89%), " hyperaemia "(78%), "pain" (67%), and"burnings/stinging" (33%). Regarding the risk factors for extravasation, the most cited were "puncture site" (44%), "punctured limb condition" (33%), and "sclerosed veins" (33%).There was no consensus on the correct order to veinipuncture previous to the chemotherapy performance. Extravasation prevention is a constant concern in the nurses clinical practice.This study shows the importance of nursing care refresher training and the elaboration of clinical guidelines, so that professionals can identify patients at higher risk of extravasavion aiming at preventing its occurrence instead of treating it afterwards.Downloads
References
1. Bonassa EMA, Santana TR. Enfermagem em terapêutica oncológica. 3ª ed. São Paulo: Atheneu; 2005.
2. Schrijvers DL. Extravasation: a dreaded complication of chemotherapy. Ann Oncol. 2003; 14(3): 26-30.
3. Alley E, Green R, Schuchter L. Cutaneous toxicities of cancer therapy. Curr Opin Oncol. 2002; 14: 212-16.
4. Ferreira MT, Reis PED, Gomes IP. Antineoplasic chemotherapy extravasation prevention: integrative review. Online Braz J Nurs. 2008; 7(3).
5. Adami M, Moreira AM, Rudo■ BFT, et al. Extravasamento de drogas antineoplásicas: notificação e cuidados prestados.
Rev Bras Cancerol. 2001; 47 (2): 143-51.
6. Brunherotti MR. Intervenções no extravasamento de quimioterápicos vesicantes: revisão integrativa de literatura [Dissertação]. Escola de enfermagem de Ribeirão Preto (USP); 2007.
7. Reis PED, Capucho CR, Vasques CI, et al. Efeitos adversos identificados em local de infusão intravenosa periférica por drogas quimioterápicas. Cienc Enferm. 2008; 14(2): 55-64.
8. Brasil. Conselho Federal de Enfermagem. Resolução n■ 210 de 1 de julho de 1998. [Citado 2010 ago. 06]. Disponível em:
9. Grundy M. Chemotherapy administration by nurses: an Audit of practice and educational preparation. Report and executive summary, National Board for Nursing, Midwifery and Health Visiting for Scotland, Edinburgh; 1998.
10. Verity R, Wiseman T, Ream E, et al. Exploring the work of nurses who administer chemotherapy. Eur J Oncol Nurs. 2008;
12: 244-52.
11. Sanborn RE, Sauer DA. Cutaneous reactions to chemotherapy: commonly seen, less described, little understood. Dermatol Clin. 2008; 26: 103-19.
12. Sauerland C, Engelking C, Wickham R, et al. Vesicant extravasation part I: mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum. 2006; 33 (6): 1134-41.
13. Hadaway L. Infiltration and extravasation: preventing a complication of IV catheterization. AJN. 2007; 107(8): 64-72.
14. Wengström Y, Margulies A. European oncology nursing society extravasation guidelines. Eur J Oncol Nurs. 2008; 12:357-61.
15. Schulmeister L. Managing vesicant extravasations. Oncologist. 2008;13(3): 284-8.
16. Viale PH. Chemotherapy and cutaneous toxicities: implications for oncology nurses. Sem Oncol Nurs. 2006; 22(3):144-51.
17. Cabrera ML, Liberatti M. Lesões por extravasamento de quimioterápicos: prevenção e conduta. Acta Oncol Bras. 1986;6: 113-7.
18. Polovich M, White J, Keleher L. Chemotherapy and biotherapy guidelines and recommendations for practice. Philadelphia: Oncology Nursing Society; 2005.
19. Kassner E. Evaluation and Treatment of Chemotherapy. J Ped Oncol Nurs 2000; 17 (3): 135-48.
20. Steiert A, Hille U, Burke W, et al. Subcutaneous wash-out procedure (SWOP) for the treatment of chemotherapeuticextravasations. J PlastReconstr Aesthet Surg. 2010; 20:1-8.
21. Villarín AJL, Belda JN. Prevención y tratamiento de las extravasaciones de quimioterapia intravenosa. Enferm Clín. 2004;14(2): 122-6.
22. Schulmeister L. Vesicant chemotherapy extravasation antidotes and treatments. Clin J Oncol Nurs. 2009; 13(4): 395-8.
23. Salci MA, Marcon SS. As mudanças no cotidiano familiar e na vida da mulher após o início do tratamento para o câncer.REME Rev Min Enferm. 2010; 14(1): 37-42.
24. Friedho■er H, Carramashi F, Calonge H, et al. Tratamento de lesões cutâneas causadas por extravasamento de adriamicina. Rev Paul Med. 1988; 106(4): 197-200.
25. Silva ACP. Extravasamento de drogas vesicantes: relato de experiência. Rev Paul Enferm. 1992; 11(1): 27-9.
26. How C, Brown J. Extravasation of cytotoxic chemoterapy fromperipheral veins. Eur J Oncol Nurs. 1998; 2(1): 51-8.
27. Saniger MA, García DL, Arrazola AR. Complicaciones más frecuentes de la administración intravenosa de fármacos: flebitis y extravasación.Enferm Clín. 2002; 12(2): 80-5.
28. Luke E. Mitoxantrone-induced extravasation. Oncol Nurs Forum. 2005; 32: 27-9
Downloads
Published
Issue
Section
License
Copyright (c) 2011 Reme: Revista Mineira de Enfermagem
This work is licensed under a Creative Commons Attribution 4.0 International License.
Links
Facebook
Instagram
Twitter
